Ardelyx (ARDX) Capital Expenditures (2013 - 2026)
Ardelyx's Capital Expenditures came in at $13,000 for Q2 2026, down 98.0% from $650,000 a year earlier and down 81.2% from the prior quarter.
Ardelyx (ARDX) Capital Expenditures (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ardelyx reported Capital Expenditures of $599,000, down 64.9% year-over-year; for FY2025, it was $1.49 million, up 47.6% from FY2024.
- Capital Expenditures has increased in each of the last three years, with a five-year compound annual growth rate of 35.7% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $1.01 million in FY2024 (+193.9%), $344,000 in FY2023 (+525.5%), $55,000 in FY2022 (-97.1%) and $1.87 million in FY2021 (+476.2%).
- The Q2 2026 figure represents the lowest quarterly Capital Expenditures since Q4 2021.
- Year-over-year, Capital Expenditures has declined for three consecutive quarters, with growth averaging 40.2% over the last seven quarters.
- The fastest year-over-year change in Capital Expenditures over five years came in Q1 2024 (growth of 971.4%), and the weakest in Q2 2026 (a decline of 98.0%).
- Business Quant data shows ARDX's Capital Expenditures at $69,000 (Q1 2026), $361,000 (Q4 2025) and $156,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -321.00 Mn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -763.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Ardelyx | 842.12 Mn | -185.18 Mn | 115.12 Mn | 13,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13,000.00 |
| Mar 31, 2026 | 69,000.00 |
| Dec 31, 2025 | 361,000.00 |
| Sep 30, 2025 | 156,000.00 |
| Jun 30, 2025 | 650,000.00 |
| Mar 31, 2025 | 325,000.00 |
| Dec 31, 2024 | 593,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 131,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Sep 30, 2023 | 194,000.00 |
| Jun 30, 2023 | 93,000.00 |
| Mar 31, 2023 | 14,000.00 |
| Dec 31, 2022 | 55,000.00 |
| Dec 31, 2021 | -95,000.00 |
| Sep 30, 2021 | 445,000.00 |
| Jun 30, 2021 | 739,000.00 |
| Mar 31, 2021 | 778,000.00 |
| Dec 31, 2020 | 250,000.00 |
Ardelyx Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ARDX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ARDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ARDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();